Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains
  1. Home
  3. Research Domains

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Wnt/tcf Signaling Through Lef1 And Hoxb9 Mediates Lung Adenocarcinoma Metastasis.
  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Wnt/tcf Signaling Through Lef1 And Hoxb9 Mediates Lung Adenocarcinoma Metastasis.

    • Related Experiment Videos

    WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

    Don X Nguyen1, Anne C Chiang, Xiang H-F Zhang

    • 1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

    Cell
    |July 7, 2009

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    The WNT/TCF pathway drives rapid lung adenocarcinoma metastasis to the brain and bone. Targeting this pathway, specifically HOXB9 and LEF1, may inhibit cancer spread.

    Related Experiment Videos

    Area of Science:

    • Oncology
    • Molecular Biology
    • Cancer Metastasis

    Background:

    • Lung adenocarcinoma can metastasize rapidly to multiple organs.
    • The underlying mechanisms driving this swift metastatic capacity remain largely unknown.
    • Understanding these mechanisms is crucial for developing effective therapeutic strategies.

    Purpose of the Study:

    • To identify the molecular mechanisms responsible for rapid lung adenocarcinoma metastasis.
    • To investigate the role of the WNT/TCF pathway in brain and bone metastasis.
    • To determine the specific WNT/TCF target genes involved in mediating metastasis.

    Main Methods:

    • Analysis of gene expression signatures in primary lung adenocarcinoma.
    • Isolation and characterization of metastatic subpopulations from cell lines.
    • In vivo studies using mouse models to assess the impact of WNT/TCF pathway modulation on metastasis.
    • Identification and validation of WNT/TCF target genes.

    Main Results:

    • Activation of the canonical WNT/TCF pathway is a key determinant of lung adenocarcinoma metastasis to the brain and bone.
    • WNT/TCF pathway activation signatures correlate with multi-organ relapse in primary tumors.
    • Hyperactive WNT/TCF pathway in metastatic subpopulations was observed.
    • Reducing TCF activity decreased the ability to form brain and bone metastases in mice, independent of primary tumor growth.
    • HOXB9 and LEF1 were identified as critical WNT/TCF target genes mediating invasion and colonization.

    Conclusions:

    • The WNT/TCF signaling pathway plays a critical role in enabling lung adenocarcinoma cells to metastasize to the brain and bone.
    • Specific WNT/TCF target genes, HOXB9 and LEF1, are essential mediators of this metastatic process.
    • Targeting the WNT/TCF pathway and its downstream effectors presents a potential therapeutic strategy to inhibit lung adenocarcinoma metastasis.